BD0801

· Jiangsu Simcere Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BD0801, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer [Phase 3]

See pricing